TLR4 signalling in osteoarthritis-finding targets for candidate DMOADs

Nature Reviews Rheumatology

Volumn 11, Issue 3, 2015, Pages 159-170

  Gómez, Rodolfo ^a   Villalvilla, Amanda ^b   Largo, Raquel ^b   Gualillo, Oreste ^c   Herrero Beaumont, Gabriel ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITY OF VIGO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; AMYLOID BETA PROTEIN; BOSWELLIC ACID; CALGRANULIN A; CD14 ANTIGEN; CD36 ANTIGEN; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DISEASE MODIFYING OSTEOARTHRITIC DRUG; FATTY ACID; FIBRONECTIN; GINKGO BILOBA EXTRACT; GLOBULIN; HEPARAN SULFATE; HIGH MOBILITY GROUP B1 PROTEIN; HYALURONIC ACID; KAMPFEROL; OLEOCANTHAL; OXIDIZED LOW DENSITY LIPOPROTEIN; PATTERN RECOGNITION RECEPTOR; PROTEIN MD 2; QUERCETIN; RESATORVID; SERUM AMYLOID A; TENASCIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG; URATE; VITAMIN D BINDING PROTEIN;

AGING; ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; BONE TISSUE; CARTILAGE; GENE; HUMAN; INFLAMMATION; INFRAPATELLAR FAT PAD; INNATE IMMUNITY; NEUROPATHIC PAIN; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RECEPTOR BLOCKING; REVIEW; SIGNAL TRANSDUCTION; SYNOVIUM; TLR4 GENE; ANIMAL; METABOLISM; PATHOLOGY;

ANIMALS; HUMANS; OSTEOARTHRITIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84924193415     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2014.209     Document Type: Review

References (139)

1. Dvinge, H. & Bertone, P. A meta-Analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage 13, 769-781 (2005
2. Reynard, L. N. & Loughlin, J. Genetics and epigenetics of osteoarthritis. Maturitas 71, 200-204 (2012
3. Gómez, R., et al. Whats new in our understanding of the role of adipokines in rheumatic diseases? Nat. Rev. Rheumatol. 7, 528-536 (2011
4. Herrero-Beaumont, G. & Roman-Blas, J. A. Osteoarthritis: Osteoporotic OA: a reasonable target for bone-Acting agents. Nat. Rev. Rheumatol. 9, 448-450 (2013
5. Scanzello, C. R., Plaas, A. & Crow, M. K. Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr. Opin. Rheumatol. 20, 565-572 (2008
6. Janeway, C. A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 (Pt 1), 1-13 (1989
7. Medzhitov, R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135-145 (2001
8. Abdollahi-Roodsaz, S., van de Loo, F. A. & van den Berg, W. B. Trapped in a vicious loop: Toll-like receptors sustain the spontaneous cytokine production by rheumatoid synovium. Arthritis Res. Ther. 13, 105 (2011
9. Goldring, S. R. & Scanzello, C. R. Plasma proteins take their toll on the joint in osteoarthritis. Arthritis Res. Ther. 14, 111 (2012
10. Chen, K., et al. Toll-like receptors in inflammation, infection and cancer. Int. Immunopharmacol. 7, 1271-1285 (2007
11. Keshava Prasad, T. S., et al. Human Protein Reference Database-2009 update. Nucleic Acids Res. 37, D767-D772 (2009
12. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997
13. Chaturvedi, A. & Pierce, S. K. How location governs Toll-like receptor signaling. Traffic 10, 621-628 (2009
14. Gangloff, M. Different dimerisation mode for TLR4 upon endosomal acidification? Trends Biochem. Sci. 37, 92-98 (2012
15. Da Silva Correia, J. & Ulevitch, R. J. MD 2 and TLR4 N linked glycosylations are important for a functional lipopolysaccharide receptor. J. Biol. Chem. 277, 1845-1854 (2002
16. Raijmakers, R., Kraiczek, K., de Jong, A. P., Mohammed, S. & Heck, A. J. Exploring the human leukocyte phosphoproteome using a microfluidic reversed phase TiO2 reversed phase high-performance liquid chromatography phosphochip coupled to a quadrupole time of flight mass spectrometer. Anal. Chem. 82, 824-832 (2010
17. Medvedev, A. E., et al. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J. Biol. Chem. 282, 16042-16053 (2007
18. Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A. & Bazan, J. F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl Acad. Sci. USA 95, 588-593 (1998
19. Wang, P., Zhu, F., Tong, Z & Konstantopoulos, K. Response of chondrocytes to shear stress: antagonistic effects of the binding partners Toll-like receptor 4 and caveolin 1. FASEB J. 25, 3401-3415 (2011
20. Midwood, K., et al. Tenascin C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 15, 774-780 (2009
21. Kikuchi, T., et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 166, 3574-3579 (2001
22. Stewart, C. R., et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155-161 (2010
23. Sohn, D. H., et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res. Ther. 14, R7 (2012
24. Liu-Bryan, R. & Terkeltaub, R. Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis Rheum. 62, 2004-2012 (2010
25. Yang, H., et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl Acad. Sci. USA 107, 11942-11947 (2010
26. Frommer, K. W., et al. Free fatty acids: potential proinflammatory mediators in rheumatic diseases. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2013-203755
27. Lee, J. Y., et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 279, 16971-16979 (2004
28. Scott, P., Ma, H., Viriyakosol, S., Terkeltaub, R. & Liu-Bryan, R. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J. Immunol. 177, 6370-6378 (2006
29. De Seny, D., et al. Acute-phase serum amyloid A in osteoarthritis: regulatory mechanism and proinflammatory properties. PLoS ONE 8, e66769 (2013
30. Tsukamoto, H., Fukudome, K., Takao, S., Tsuneyoshi, N. & Kimoto, M. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-Associated CD14-expressing cells. Int. Immunol. 22, 271-280 (2010
31. Haziot, A., et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 4, 407-414 (1996
32. Lien, E., et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105, 497-504 (2000
33. Poltorak, A., Ricciardi-Castagnoli, P., Citterio, S. & Beutler, B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc. Natl Acad. Sci. USA 97, 2163-2167 (2000
34. Da Silva Correia, J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD 2. J. Biol. Chem. 276, 21129-21135 (2001
35. Tsan, M. F. & Gao, B. Pathogen-Associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors. J. Endotoxin Res. 13, 6-14 (2007
36. Marincek, B. C., et al. Heat shock protein-Antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion. Mol. Immunol. 46, 181-191 (2008
37. Luong, M., et al. Stimulation of TLR4 by recombinant HSP70 requires structural integrity of the HSP70 protein itself. J. Inflamm (Lond.) 9, 11 (2012
38. Okamura, Y., et al. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 10229-10233 (2001
39. Schelbergen, R F. P., et al. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4. Arthritis Rheum. 64, 1477-1487 (2012
40. Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511 (2004
41. Takeda, K. & Akira, S. TLR signaling pathways. Semin. Immunol. 16, 3-9 (2004
42. Lin, S. C., Lo, Y. C. & Wu, H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL 1R signalling. Nature 465, 885-890 (2010
43. Motshwene, P. G., et al. An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK 4. J. Biol. Chem. 284, 25404-25411 (2009
44. Goldring, M. B. & Goldring, S. R. Osteoarthritis. J. Cell Physiol. 213, 626-634 (2007
45. Kagan, J. C., et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon β. Nat. Immunol. 9, 361-368 (2008
46. Tanimura, N., Saitoh, S., Matsumoto, F., Akashi-Takamura, S. & Miyake, K. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem. Biophys. Res. Commun. 368, 94-99 (2008
47. Bonham, K. S., et al. A promiscuous lipid-binding protein diversifies the subcellular sites of Toll-like receptor signal transduction. Cell 156, 705-716 (2014
48. Sillat, T., et al. Toll-like receptors in human chondrocytes and osteoarthritic cartilage. Acta Orthop. 84, 585-592 (2013
49. Karlsson, C., et al. Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis Cartilage 18, 581-592 (2010
50. Kim, H. A., et al. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum. 54, 2152-2163 (2006
51. Bobacz, K., et al Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of Toll-like receptor 4 and antagonized by bone morphogenetic protein 7. Arthritis Rheum. 56, 1880-1893 (2007
52. Abdollahi-Roodsaz, S., et al. Local interleukin 1 driven joint pathology is dependent on Toll-like receptor 4 activation. Am. J. Pathol. 175, 2004-2013 (2009
53. Haglund, L., Bernier, S. M., Onnerfjord, P. & Recklies, A. D. Proteomic analysis of the LPS-induced stress response in rat chondrocytes reveals induction of innate immune response components in articular cartilage. Matrix Biol. 27, 107-118 (2008
54. Verzijl, N., et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem. J. 350 (Pt 2), 381-387 (2000
55. Chen, Y. J., Sheu, M. L., Tsai, K. S., Yang, R. S. & Liu, S. H. Advanced glycation end products induce peroxisome proliferator-Activated receptor γ down regulation related inflammatory signals in human chondrocytes via Toll-like receptor 4 and receptor for advanced glycation end products. PLoS ONE 8, e66611 (2013
56. Hardy, M. M., et al. Cyclooxygenase 2 dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum. 46, 1789-1803 (2002
57. Miller, C., et al. Transcriptional induction of cyclooxygenase 2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP 1 and CRE nuclear binding proteins. J. Cell Biochem. 69, 392-413 (1998
58. Wang, P., Zhu, F & Konstantopoulos, K. Interleukin 6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15 deoxy ?12, 14-PGJ2. PLoS ONE 6, e27630 (2011
59. Álvarez-Soria, M. A., et al. Long-Term NSAID treatment directly decreases COX 2 and mPGES 1 production in the articular cartilage of patients with osteoarthritis. Osteoarthritis Cartilage 16, 1484-1493 (2008
60. Abramson, S. B., Attur, M., Amin, A. R. & Clancy, R. Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr. Rheumatol. Rep. 3, 535-541 (2001
61. Pelletier, J. P., Mineau, F., Ranger, P., Tardif, G. & Martel-Pelletier, J. The increased synthesis of inducible nitric oxide inhibits IL 1RA synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 4, 77-84 (1996
62. Stadler, J., et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J. Immunol. 147, 3915-3920 (1991
63. Wu, G. J., et al. Nitric oxide from both exogenous and endogenous sources activates mitochondria-dependent events and induces insults to human chondrocytes. J. Cell Biochem. 101, 1520-1531 (2007
64. Gómez, R., et al. Nitric oxide boosts TLR 4 mediated lipocalin 2 expression in chondrocytes. J. Orthop. Res. 31, 1046-1052 (2013
65. Conde, J., et al. Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann. Rheum. Dis. 70, 551-559 (2011
66. Ayral, X., Pickering, E. H., Woodworth, T. G., McKillop, N. & Dougados, M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis-results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 13, 361-367 (2005
67. Ospelt, C., et al. Overexpression of Toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 58, 3684-3692 (2008
68. Jung, Y. O., et al. Synergism of Toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-α in a spontaneous arthritis animal model of interleukin (IL) 1 receptor antagonist-deficient mice. Immunol. Lett. 123, 138-143 (2009
69. Sanchez, C., et al. Regulation of subchondral bone osteoblast metabolism by cyclic compression. Arthritis Rheum. 64, 1193-1203 (2011
70. Chiba, K., et al. Osteoporotic changes of subchondral trabecular bone in osteoarthritis of the knee: a 3 T MRI study. Osteoporos. Int. 23, 589-597 (2012
71. Zhang, L. Z., et al. Mechanical and biologic link between cartilage and subchondral bone in osteoarthritis. Arthritis Care Res. 64, 960-967 (2012
72. Zhen, G. & Cao, X. Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis. Trends Pharmacol. Sci. 35, 227-236 (2014
73. Lacourt, M., et al. Relationship between cartilage and subchondral bone lesions in repetitive impact trauma-induced equine osteoarthritis. Osteoarthritis Cartilage 20, 572-583 (2012
74. Zou, W., Amcheslavsky, A. & Bar-Shavit, Z. CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9. J. Biol. Chem. 278, 16732-16740 (2003
75. Nemoto, E., Honda, T., Kanaya, S., Takada, H. & Shimauchi, H. Expression of functional Toll-like receptors and nucleotide-binding oligomerization domain proteins in murine cementoblasts and their upregulation during cell differentiation. J. Periodont. Res. 43, 585-593 (2008
76. Gao, A., Kantarci, A., Herrera, B. S., Gao, H. & Van Dyke T. E. A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase 13 in osteoblasts. PeerJ 1, e51 (2013
77. Inada, M., Matsumoto, C., Uematsu, S., Akira, S. & Miyaura, C. Membrane-bound prostaglandin E synthase 1 mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation. J. Immunol. 177, 1879-1885 (2006
78. Nakao, J., et al. Low-intensity pulsed ultrasound (LIPUS) inhibits LPS-induced inflammatory responses of osteoblasts through TLR4-MyD88 dissociation. Bone 58, 17-25 (2013
79. Bandow, K., et al. Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation. Biochem. Biophys. Res. Commun. 402, 755-761 (2010
80. Huang, R. L., et al. LPS-stimulated inflammatory environment inhibits BMP 2 induced osteoblastic differentiation through crosstalk between TLR4/MyD88/NF ?B and BMP/Smad signaling. Stem Cells Dev. 23, 277-289 (2014
81. Raicevic, G., et al. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin. Tissue Eng. Part A 18, 1410-1418 (2012
82. Kim, Y. S., et al. Increased circulating heat shock protein 60 induced by menopause, stimulates apoptosis of osteoblast-lineage cells via up-regulation of Toll-like receptors. Bone 45, 68-76 (2009
83. Liu, J., et al. Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis. J. Biol. Chem. 284, 12512-12523 (2009
84. Itoh, K., et al. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J. Immunol. 170, 3688-3695 (2003
85. Clockaerts, S., et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage 18, 876-882 (2010
86. Eymard, F., et al Infrapatellar fat pad induces an inflammatory and a pro-degradative phenotype in autologous fibroblast-like synoviocytes from patients with knee OA. Arthritis Rheumatol. 66, 2165-2174 (2014
87. Klein-Wieringa, I. R., et al. The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann. Rheum. Dis. 70, 851-857 (2011
88. Distel, E., et al. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin 6 and its soluble receptor. Arthritis Rheum. 60, 3374-3377 (2009
89. Bès-Houtmann, S., et al. Presence of functional TLR2 and TLR4 on human adipocytes. Histochem. Cell Biol. 127, 131-137 (2007
90. Orr, J. S., et al. Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes 61, 2718-2727 (2012
91. Davis, J. E., Gabler, N. K., Walker-Daniels, J. & Spurlock, M. E. TLR 4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 16, 1248-1255 (2008
92. Jia, L., et al. Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance. Nat. Commun. 5, 3878 (2014
93. Campo, G. M., et al. Small hyaluronan oligosaccharides induce inflammation by engaging both Toll-like 4 and CD44 receptors in human chondrocytes. Biochem. Pharmacol. 80, 480-490 (2010
94. Campo, G. M., et al. Hyaluronan differently modulates TLR 4 and the inflammatory response in mouse chondrocytes. Biofactors 38, 69-76 (2012
95. Wähämaa, H., et al. High mobility group box protein 1 in complex with lipopolysaccharide or IL 1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis Res. Ther. 13, R136 (2011
96. Sofat, N. Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int. J. Exp. Pathol. 90, 463-479 (2009
97. Homandberg, G. A., Meyers, R. & Xie, D. L. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J. Biol. Chem. 267, 3597-3604 (1992
98. Xie, D. L., Meyers, R. & Homandberg, G. A. Fibronectin fragments in osteoarthritic synovial fluid. J. Rheumatol. 19, 1448-1452 (1992
99. Brown, R. A. & Jones, K. L. The synthesis and accumulation of fibronectin by human articular cartilage. J. Rheumatol. 17, 65-72 (1990
100. Zhen, E. Y., et al. Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheum. 58, 2420-2431 (2008
101. Sofat, N. Robertson, S. D. & Wait, R. Fibronectin III 13-14 domains induce joint damage via Toll-like receptor 4 activation and synergize with interleukin 1 and tumour necrosis factor. J. Innate Immun. 4, 69-79 (2011
102. Zreiqat, H., et al. S100A8 and S100A9 in experimental osteoarthritis. Arthritis Res. Ther. 12, R16 (2010
103. Kalichman, L. & Kobyliansky, E. Hand osteoarthritis in Chuvashian population: prevalence and determinants. Rheumatol. Int. 30, 85-92 (2009
104. Villalvilla, A., Gómez, R., Largo, R. & Herrero-Beaumont, G. Lipid transport and metabolism in healthy and osteoarthritic cartilage. Int. J. Mol. Sci. 14, 20793-20808 (2013
105. Cillero-Pastor, B., Eijkel, G., Kiss, A., Blanco, F. J. & Heeren, R. M. Time of flight secondary ion mass spectrometry-based molecular distribution distinguishing healthy and osteoarthritic human cartilage. Anal. Chem. 84, 8909-8916 (2012
106. Alvarez-Garcia, O., Rogers, N H., Smith, R. G. & Lotz, M. K. Palmitate has proapoptotic and proinflammatory effects on articular cartilage and synergizes with interleukin 1. Arthritis Rheumatol. 66, 1779-1788 (2014
107. Moisio, K., et al. Denuded subchondral bone and knee pain in persons with knee osteoarthritis. Arthritis Rheum. 60, 3703-3710 (2009
108. Ballegaard, C., et al. Knee pain and inflammation in the infrapatellar fat pad estimated by conventional and dynamic contrast-enhanced magnetic resonance imaging in obese patients with osteoarthritis: a cross-sectional study. Osteoarthritis Cartilage 22, 933-940 (2014
109. Hill, C. L., et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann. Rheum. Dis. 66, 1599-1603 (2007
110. Liu, T., Gao, Y. J. & Ji, R. R. Emerging role of Toll-like receptors in the control of pain and itch. Neurosci. Bull. 28, 131-144 (2012
111. Tanga, F. Y., Nutile-McMenemy, N. & DeLeo, J. A. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl Acad. Sci. USA 102, 5856-5861 (2005
112. Campo, G M., et al. Adenosine A2A receptor activation and hyaluronan fragment inhibition reduce inflammation in mouse articular chondrocytes stimulated with interleukin 1β. FEBS J. 279, 2120-2133 (2012
113. Chang, E. J., et al. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J. Cell Sci. 120, 166-176 (2007
114. Vasheghani, F., et al. Adult cartilage-specific peroxisome proliferator-Activated receptor γ knockout mice exhibit the spontaneous osteoarthritis phenotype. Am. J. Pathol. 182, 1099-1106 (2013
115. Juarranz, Y., et al. VIP decreases TLR4 expression induced by LPS and TNF α treatment in human synovial fibroblasts. Ann. NY Acad. Sci. 1070, 359-364 (2006
116. Haskó, G., Linden, J., Cronstein, B. & Pacher, P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7, 759-770 (2008
117. Campo, G. M., et al. The stimulation of adenosine 2A receptor reduces inflammatory response in mouse articular chondrocytes treated with hyaluronan oligosaccharides. Matrix Biology 31, 338-351 (2012
118. Peri, F. & Piazza, M. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists. Biotechnol. Adv. 30, 251-260 (2012
119. Iacono, A., et al. Effect of oleocanthal and its derivatives on inflammatory response induced by lipopolysaccharide in a murine chondrocyte cell line. Arthritis Rheum. 62, 1675-1682 (2010
120. Chen, Y. J., et al. EGb761 inhibits inflammatory responses in human chondrocytes and shows chondroprotection in osteoarthritic rat knee. J. Orthop. Res. 31, 1032-1038 (2013
121. Villalvilla, A., et al. 6 Shogaol inhibits chondrocytes innate immune responses and cathepsin K activity. Mol. Nutr. Food Res. 58, 256-266 (2014
122. Ahn, S. I., Lee, J. K. & Youn, H. S. Inhibition of homodimerization of Toll-like receptor 4 by 6 shogaol. Mol. Cells 27, 211-215 (2009
123. Wang, Q., et al. Oral and topical boswellic acid attenuates mouse osteoarthritis. Osteoarthritis Cartilage 22, 128-132 (2014
124. Barochia, A., Solomon, S., Cui, X., Natanson, C. & Eichacker, P. Q. Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies. Expert Opin. Drug Metab. Toxicol. 7, 479-494 (2011
125. Shirey, K. A., et al. The TLR4 antagonist eritoran protects mice from lethal influenza infection. Nature 497, 498-502 (2013
126. Neal, M. D., et al. Discovery and validation of a new class of small molecule Toll-like receptor 4 (TLR4) inhibitors. PLoS ONE 8, e65779 (2013
127. Shang, L., et al. Selective antibody intervention of Toll-like receptor 4 activation through Fc γ receptor tethering. J. Biol. Chem. 289, 15309-15318 (2014
128. Piao, W., Vogel, S. N. & Toshchakov, V. Y. Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo. J. Immunol. 190, 2263-2272 (2013
129. Hutchinson, M. R., et al. Evidence that tricyclic small molecules may possess Toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience 168, 551-563 (2010
130. Hutchinson, M. R., et al. Evidence that opioids may have Toll-like receptor 4 and MD 2 effects. Brain Behav. Immun. 24, 83-95 (2010
131. Piazza, M., et al. Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets. Innate Immun. 17, 293-301 (2011
132. Noman, A. S. M., et al. Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor α production via down-regulation of MyD88 expression. Innate Immun. 15, 33-41 (2009
133. Chevalier, X., et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 61, 344-352 (2009
134. Bellido, M., et al. Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. Osteoarthritis Cartilage 19, 1228-1236 (2011
135. WHO. Chronic diseases and health promotion. Chronic rheumatic conditions [online], http://www.who.int/chp/topics/rheumatic/en/(2014
136. Wan, Y. PPARγ in bone homeostasis. Trends Endocrinol. Metab. 21, 722-728 (2010
137. Gosset, P., et al. Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response. Eur. J. Immunol. 35, 1491-1500 (2005
138. Arima, M. & Fukuda, T. Prostaglandin D2 receptors DP and CRTH2 in the pathogenesis of asthma. Curr. Mol. Med. 8, 365-375 (2008
139. Schindler, C. W., et al. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists. Br. J. Pharmacol. 144, 642-650 (2005